
Julie Freischlag will retire at the end of 2025 as CEO of Atrium Health Wake Forest Baptist
Atrium Health Wake Forest Baptist shared a post on LinkedIn:
“After more than 32 years as an academic medicine leader, Dr. Julie Freischlag will retire at the end of 2025 as CEO and chief academic officer of Atrium Health Wake Forest Baptist, chief academic officer and executive vice president of Advocate Health and executive vice president of health affairs at Wake Forest University. She will also conclude her 38-year career as a practicing vascular surgeon.
Dr. Freischlag’s career has been marked by numerous accolades, including the 2023 Lifetime Achievement Award from the Society for Vascular Surgery, recognizing her life-saving work and contributions to the education of future medical professionals.
Reflecting on her decision to retire, Dr. Freischlag expressed, ‘Leading Wake Forest Baptist has been the most fulfilling and rewarding role in my medical career. I have been inspired and energized every day by the dedication of our teams to our patients and the communities we serve and am incredibly proud of our growing commitment as an academic learning health system to teach, train and discover.’
Dr. Freischlag will leave a lasting impact on the health care industry, our teammates and patients’ lives. Thank you for your leadership, dedication and commitment to all, Dr. Freischlag!
More on this announcement here.”
Ruben Mesa, President at Atrium Health, shared Atrium Health Wake Forest Baptist’s post on LinkedIn:
“Dr Julie Freischlag is one of the finest leaders I have worked with during my career! She is the very embodiment of the Loved One Standard we strive for at Advocate Health and Wake Forest University School of Medicine! Thank you Julie for all you have done for Atrium Health Wake Forest Baptist, for Women In Medicine and for Academic Medicine.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023